Thiazolidinedione-induced activation of the transcription factor peroxisome proliferator-activated receptor gamma in cells adjacent to the murine skeletal muscle: implications for fibroblast functions
B. Lohrke et al., Thiazolidinedione-induced activation of the transcription factor peroxisome proliferator-activated receptor gamma in cells adjacent to the murine skeletal muscle: implications for fibroblast functions, PFLUG ARCH, 439(3), 2000, pp. 288-296
Nuclear peroxisome proliferator-activated receptor gamma (PPAR gamma) is th
e target of antidiabetogenic thiazolidinediones (TZD). However, recent stud
ies failed to show that TZD has an effect in vitro on insulin-regulated glu
cose uptake in skeletal muscles, the major site of glucose disposal. The po
tential effects of TZD on cells adjacent to skeletal muscles are not well c
haracterized but may be involved in TZD's actions. Hence, we studied these
cells from mice treated with the carrier and with the TZD ciglitazone (9 nm
ol/g body weight). The cells were typified by lipid enrichment (floating ad
ipocytes and macrophages), by the ectopic expression of cellular fibronecti
n (fibroblasts), fibronectin and PPAR gamma (preadipocytes), PPAR gamma and
CD11b/Mac-1 (active macrophages) as revealed by flow cytometry and immunob
lotting. The glucose transporter 4 proteins (GLUT4) and the uptake of gluco
se and long-chain fatty acids (LCFA) were determined flow cytometrically us
ing fluorescent derivatives of glucose (NBDG) and LCFA (C16-Bodipy). The ex
pression of tumor necrosis factor alpha (TNF alpha) in CD11b/Mac-1-positive
and CD11b/Mac-1-negative cells separated by magnetic immunobeads was analy
zed. The results showed that TZD treatment upregulated GLUT4 expression, an
d increased insulin-regulated NBDG uptake and C16-Bodipy binding and influx
, at the same time as increasing the quantity of PPAR gamma-expressing fibr
oblasts; this indicates the development of the preadipocyte phenotype. In c
ontrast, TZD lowered the number of adipocytes (0.6-fold compared to the car
rier-treated control) perhaps through an action of TNF alpha from CD11b- an
d PPAR gamma-expressing macrophages. The data suggest that the regulatory e
ffects of TZD on energy homeostasis involve two major targets: the PPAR gam
ma-positive fibroblasts whose adipogenic program is promoted, and CD11b-PPA
R gamma-expressing macrophages which become cytotoxic and fibrogenic becaus
e of the effects of TNF alpha on neighboring adipocytes and fibroblasts, re
spectively.